[Congressional Record (Bound Edition), Volume 160 (2014), Part 11]
[Extensions of Remarks]
[Page 16326]
[From the U.S. Government Publishing Office, www.gpo.gov]




               CELEBRATING BIOMARIN PHARMACEUTICALS INC.

                                 ______
                                 

                           HON. JARED HUFFMAN

                             of california

                    in the house of representatives

                        Monday, December 1, 2014

  Mr. HUFFMAN. Mr. Speaker, it is my pleasure to acknowledge BioMarin 
Pharmaceuticals on the occasion of the company's recognition by Forbes 
Magazine as the 7th Most Innovative Company in the World for 2014. 
Selection as one of the world's ten most innovative companies is no 
small accomplishment and is a testament to BioMarin's ability to 
efficiently provide patients with new solutions to challenging chronic 
and degenerative genetic conditions.
  Forbes' ranking relies on the ability of investors to identify which 
companies will continue to spur innovation now and in the future. Given 
BioMarin's past success in pioneering new medical treatments, the 
company's high ranking is well deserved.
  Since 1997, BioMarin has developed and commercialized five medical 
treatments, a remarkable feat in the biopharmaceutical industry. The 
company has been recognized as one of the nation's fastest drug 
developers, bringing new treatments to market 12 months sooner than the 
industry median. For the patients with rare and often severe 
conditions, one year can make a lifetime of difference.
  The innovative work of BioMarin staff, from the leadership team to 
research associates, has had a lasting impact on the North Bay 
community and beyond. Please join me in congratulating BioMarin 
Pharmaceuticals on this important recognition and wishing them many 
years of future success.

                          ____________________